Overview
Product nameO-1602
DescriptionPotent, selective GPR55 agonist
Biological descriptionAnalogue of cannabidiol that is a potent agonist at the GPR55 cannabinoid receptor (EC50 values are 13, > 30000 and > 30000 nM for GPR55, CB1 and CB2 receptors respectively). Inhibits mouse osteoclast formation in vitro, stimulates osteoclast polarization and resorption, causes activation of Rho and ERK1/2, and inhibits human neutrophil migration.
Purity> 98%
General notesSold under license from Virginia Commonwealth University.
Properties
Chemical name5-Methyl-4-((1R,6R)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-enyl)benzene-1,3-diol
Molecular Weight258.36
Chemical structure
Molecular formulaC17H22O2
CAS Number317321-41-8
PubChem identifier45073499
Storage instructionsStore at -20°C (desiccating conditions).
Solubility overviewSupplied in methyl acetate (10 mg/ml)
HandlingProviding storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 6 months. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
SMILESCC(=C)[C@@H]2CCC(C)=C[C@H]2c1c(C)cc(O)cc1O
SourceSynthetic
Research Areas
References for O-1602 (ab120407)
This product has been referenced in:
- Whyte LS et al. The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proc Natl Acad Sci U S A 106:16511-6 (2009).
Read more (PubMed: 19805329) »
- McHugh D et al. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2. Mol Pharmacol 73:441-50 (2008).
Read more (PubMed: 17965195) »
- Ryberg E et al. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152:1092-101 (2007).
Read more (PubMed: 17876302) »
See 0 Publications for this product
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"